Release Date: 16/02/12 09:22 Summary: Appendix 4D, Results Announcement and Half Year Report Price Sensitive: Yes Download Document 2.99MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling